NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.1097 (-99.73%)
Oct 7, 2025, 9:30 AM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $54.65 thousand as of October 7, 2025. Its market cap has decreased by -99.72% in one year.
Market Cap
54.65K
Enterprise Value
30.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 54.65K, a decrease of -99.98%. That is a compound annual growth rate of -98.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 54.65K | -99.77% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
| Aug 4, 2023 | 338.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |